By Margot Sanger-Katz and Rebecca Robbins The Trump administration on Friday rejected ... not ruled out coverage and “may consider future policy options” for the drugs. Medicare, the ...

The Trump administration canceled a Biden-era plan on Friday that would have made Ozempic and other weight-loss drugs ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

President Donald Trump has signed an executive order looking to modify the Inflation Reduction Act’s (IRA's) drug price ...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...

Trump and Oz have used the pretext of fighting fraud as an excuse to cut Medicare coverage. During his Senate ... life-threatening delays and outright rejections of treatment.

The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...